Central nervous system and peripheral nervous system demyelination disorders represent a class of pathologies where immune-mediated or genetic mechanisms lead to axonal degeneration via oligodendrocyte injury (CNS) or Schwann cell damage/peripheral nerve hypomyelination. Theoretical frameworks classify these conditions into autoimmune etiologies such as Multiple Sclerosis and Guillain-Barré Syndrome, viral reactivation disorders like Progressive Multifocal Leukoencephalopathy, hereditary metabolic storage diseases including Krabbe's disease and Metachromatic Leukodystrophy, and genetic structural defects exemplified by Charcot-Marie-Tooth disease. The core principle governing these domains distinguishes them based on the cellular origin of myelin loss (oligodendrocytes vs. Schwann cells), the nature of the initiating trigger (autoimmune response versus genetic enzyme deficiency or viral latency), and the specific anatomical distribution affecting either central, peripheral, or both nervous system components.
Central nervous system and peripheral nervous system demyelination disorders represent a class of pathologies where immune-mediated or genetic mechanisms lead to axonal degeneration via oligodendrocy…